Statements (33)
| Predicate | Object | 
|---|---|
| gptkbp:instanceOf | gptkb:antiviral_drug | 
| gptkbp:approvalYear | 2018 | 
| gptkbp:approvedBy | gptkb:FDA treatment of smallpox | 
| gptkbp:ATCCode | J05AX25 | 
| gptkbp:CASNumber | 869572-92-9 | 
| gptkbp:chemicalFormula | C19H15F3N2O3 | 
| gptkbp:developedBy | gptkb:SIGA_Technologies | 
| gptkbp:form | capsule solution for injection | 
| gptkbp:genericName | gptkb:tecovirimat | 
| gptkbp:legalStatus | prescription only | 
| gptkbp:marketedIn | gptkb:European_Union gptkb:United_States | 
| gptkbp:mechanismOfAction | inhibits the VP37 envelope wrapping protein | 
| gptkbp:pregnancyCategory | Not assigned (US) | 
| gptkbp:prescriptionRequired | yes | 
| gptkbp:PubChem_CID | 25154825 DB12020 | 
| gptkbp:routeOfAdministration | oral intravenous | 
| gptkbp:sideEffect | nausea vomiting abdominal pain headache | 
| gptkbp:storage | room temperature | 
| gptkbp:UNII | 6L6X5W1182 | 
| gptkbp:usedFor | gptkb:monkeypox_(off-label) orthopoxvirus infections | 
| gptkbp:bfsParent | gptkb:SIGA_Technologies gptkb:Siga_Technologies | 
| gptkbp:bfsLayer | 7 | 
| https://www.w3.org/2000/01/rdf-schema#label | TPOXX |